Tovar, V., Cornella, H., Moeini, A., Vidal, S., Hoshida, Y., Sia, D., . . . Llovet, J. M. (2015). Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma. Gut.
Style de citation ChicagoTovar, Victoria, et al. "Tumour Initiating Cells and IGF/FGF Signalling Contribute to Sorafenib Resistance in Hepatocellular Carcinoma." Gut 2015.
Style de citation MLATovar, Victoria, et al. "Tumour Initiating Cells and IGF/FGF Signalling Contribute to Sorafenib Resistance in Hepatocellular Carcinoma." Gut 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.